Atropine Sulfate Injection — FDA Drug Shortage

Current — Medefil, Inc.

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Medefil, Inc. with status Current. The shortage was first posted on Jan 1, 2012.

Shortage details

Status
Current
Company
Medefil, Inc.
Package NDC
64253-400-91
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)
Initial Posting
Jan 1, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.